668 related articles for article (PubMed ID: 26624524)
1. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
[TBL] [Abstract][Full Text] [Related]
2. PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers.
Alquézar C; Esteras N; de la Encarnación A; Alzualde A; Moreno F; López de Munain A; Martín-Requero A
Neurobiol Aging; 2014 Apr; 35(4):886-98. PubMed ID: 24139281
[TBL] [Abstract][Full Text] [Related]
3. Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia.
Alquezar C; Esteras N; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
Eur Neuropsychopharmacol; 2015 Mar; 25(3):386-403. PubMed ID: 25624003
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
Alquezar C; Esteras N; Alzualde A; Moreno F; Ayuso MS; López de Munain A; Martín-Requero Á
PLoS One; 2012; 7(5):e37057. PubMed ID: 22623979
[TBL] [Abstract][Full Text] [Related]
5. Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.
de la Encarnación A; Alquézar C; Martín-Requero Á
Mol Neurobiol; 2016 Dec; 53(10):7107-7118. PubMed ID: 26676574
[TBL] [Abstract][Full Text] [Related]
6. Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells.
Chen X; Chang J; Deng Q; Xu J; Nguyen TA; Martens LH; Cenik B; Taylor G; Hudson KF; Chung J; Yu K; Yu P; Herz J; Farese RV; Kukar T; Tansey MG
J Neurosci; 2013 May; 33(21):9202-13. PubMed ID: 23699531
[TBL] [Abstract][Full Text] [Related]
7. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
[TBL] [Abstract][Full Text] [Related]
8. Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia.
Alquezar C; Salado IG; de la Encarnación A; Pérez DI; Moreno F; Gil C; de Munain AL; Martínez A; Martín-Requero Á
Mol Neurodegener; 2016 Apr; 11(1):36. PubMed ID: 27138926
[TBL] [Abstract][Full Text] [Related]
9. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
10. Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia.
Alquezar C; Esteras N; Bartolomé F; Merino JJ; Alzualde A; López de Munain A; Martín-Requero Á
Neurobiol Aging; 2012 Feb; 33(2):429.e7-20. PubMed ID: 21232819
[TBL] [Abstract][Full Text] [Related]
11. Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia.
Krabbe G; Minami SS; Etchegaray JI; Taneja P; Djukic B; Davalos D; Le D; Lo I; Zhan L; Reichert MC; Sayed F; Merlini M; Ward ME; Perry DC; Lee SE; Sias A; Parkhurst CN; Gan WB; Akassoglou K; Miller BL; Farese RV; Gan L
Proc Natl Acad Sci U S A; 2017 May; 114(19):5029-5034. PubMed ID: 28438992
[TBL] [Abstract][Full Text] [Related]
12. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
[TBL] [Abstract][Full Text] [Related]
13. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
[TBL] [Abstract][Full Text] [Related]
14. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.
Ward ME; Chen R; Huang HY; Ludwig C; Telpoukhovskaia M; Taubes A; Boudin H; Minami SS; Reichert M; Albrecht P; Gelfand JM; Cruz-Herranz A; Cordano C; Alavi MV; Leslie S; Seeley WW; Miller BL; Bigio E; Mesulam MM; Bogyo MS; Mackenzie IR; Staropoli JF; Cotman SL; Huang EJ; Gan L; Green AJ
Sci Transl Med; 2017 Apr; 9(385):. PubMed ID: 28404863
[TBL] [Abstract][Full Text] [Related]
15. Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.
Mao Q; Wang D; Li Y; Kohler M; Wilson J; Parton Z; Shmaltsuyeva B; Gursel D; Rademakers R; Weintraub S; Mesulam MM; Xia H; Bigio EH
J Neuropathol Exp Neurol; 2017 Nov; 76(11):957-968. PubMed ID: 29044416
[TBL] [Abstract][Full Text] [Related]
16. Rare exonic variant affects GRN splicing and contributes to frontotemporal lobar degeneration.
Wauters E; Gossye H; Frydas A; Sieben A; Van Broeckhoven C
Neurobiol Aging; 2023 Oct; 130():61-69. PubMed ID: 37459659
[TBL] [Abstract][Full Text] [Related]
17. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; López de Munain A; Zulaica M; Moreno F; Le Ber I; Pasquier F; Hannequin D; Sánchez-Valle R; Antonell A; Lladó A; Parsons TM; Finch NA; Finger EC; Lippa CF; Huey ED; Neumann M; Heutink P; Synofzik M; Wilke C; Rissman RA; Slawek J; Sitek E; Johannsen P; Nielsen JE; Ren Y; van Blitterswijk M; DeJesus-Hernandez M; Christopher E; Murray ME; Bieniek KF; Evers BM; Ferrari C; Rollinson S; Richardson A; Scarpini E; Fumagalli GG; Padovani A; Hardy J; Momeni P; Ferrari R; Frangipane F; Maletta R; Anfossi M; Gallo M; Petrucelli L; Suh E; Lopez OL; Wong TH; van Rooij JGJ; Seelaar H; Mead S; Caselli RJ; Reiman EM; Noel Sabbagh M; Kjolby M; Nykjaer A; Karydas AM; Boxer AL; Grinberg LT; Grafman J; Spina S; Oblak A; Mesulam MM; Weintraub S; Geula C; Hodges JR; Piguet O; Brooks WS; Irwin DJ; Trojanowski JQ; Lee EB; Josephs KA; Parisi JE; Ertekin-Taner N; Knopman DS; Nacmias B; Piaceri I; Bagnoli S; Sorbi S; Gearing M; Glass J; Beach TG; Black SE; Masellis M; Rogaeva E; Vonsattel JP; Honig LS; Kofler J; Bruni AC; Snowden J; Mann D; Pickering-Brown S; Diehl-Schmid J; Winkelmann J; Galimberti D; Graff C; Öijerstedt L; Troakes C; Al-Sarraj S; Cruchaga C; Cairns NJ; Rohrer JD; Halliday GM; Kwok JB; van Swieten JC; White CL; Ghetti B; Murell JR; Mackenzie IRA; Hsiung GR; Borroni B; Rossi G; Tagliavini F; Wszolek ZK; Petersen RC; Bigio EH; Grossman M; Van Deerlin VM; Seeley WW; Miller BL; Graff-Radford NR; Boeve BF; Dickson DW; Biernacka JM; Rademakers R
Lancet Neurol; 2018 Jun; 17(6):548-558. PubMed ID: 29724592
[TBL] [Abstract][Full Text] [Related]
18. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
[TBL] [Abstract][Full Text] [Related]
19. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
[TBL] [Abstract][Full Text] [Related]
20. FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.
Mao Q; Zheng X; Gefen T; Rogalski E; Spencer CL; Rademakers R; Fought AJ; Kohler M; Weintraub S; Xia H; Mesulam MM; Bigio EH
J Neuropathol Exp Neurol; 2019 Sep; 78(9):844-853. PubMed ID: 31361008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
